Open Access · CC BY-NC 4.0
Symptomatic Improvement in Amyotrophic Lateral Sclerosis During Low-Dose Sublingual Ketamine Treatment for Depression
Journal of Neurology Research · 2026-12 · 16 (4) · 288-298
DOI: 10.14740/jnr1140 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurology Research, 2026-12. Verfasst von Mitchell B. Liester und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Depression
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Liester, M. B., & Liang, B. (2026). Symptomatic Improvement in Amyotrophic Lateral Sclerosis During Low-Dose Sublingual Ketamine Treatment for Depression. Journal of Neurology Research, 16(4), 288-298. https://doi.org/10.14740/jnr1140
Vancouver
Liester MB, Liang B. Symptomatic Improvement in Amyotrophic Lateral Sclerosis During Low-Dose Sublingual Ketamine Treatment for Depression. Journal of Neurology Research. 2026;16(4):288-298. doi:10.14740/jnr1140
BibTeX
@article{Liester2026,
author = {Liester, Mitchell B. and Liang, Bertrand},
title = {Symptomatic Improvement in Amyotrophic Lateral Sclerosis During Low-Dose Sublingual Ketamine Treatment for Depression},
journal = {Journal of Neurology Research},
year = {2026},
volume = {16},
number = {4},
pages = {288--298},
doi = {10.14740/jnr1140}
}
EUVIMED